CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- Open-market buys, last 90 days
- $757,691
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$757,691. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-20 | Stein John Nachum Director | Purchase | +3,636 | $2.75 | $10K | 471,456 |
| 2024-11-20 | Stein John Nachum Director | Grant or award · Warrant to Purchase Common Stock | +1,818 | 1,818 | ||
| 2024-11-20 | ZELDIS JEROME B Director | Purchase | +3,636 | $2.75 | $10K | 106,664 |
| 2024-11-20 | ZELDIS JEROME B Director | Grant or award · Warrant to Purchase Common Stock | +1,818 | 1,818 | ||
| 2024-11-20 | Levy Adam R. Chief Executive Officer | Purchase | +3,636 | $2.75 | $10K | 333,196 |
| 2024-11-20 | Levy Adam R. Chief Executive Officer | Grant or award · Warrant to Purchase Common Stock | +1,818 | 1,818 | ||
| 2024-11-20 | Drapczuk Adam E III Chief Financial Officer | Purchase | +17,500 | $2.75 | $48K | 74,894 |
| 2024-11-20 | Drapczuk Adam E III Chief Financial Officer | Grant or award · Warrant to Purchase Common Stock | +8,750 | 8,750 | ||
| 2024-11-07 | Stein John Nachum Director | Gift | −4,000 | 467,820 | ||
| 2024-09-13 | Henry Scott Robert Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-09-13 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-09-13 | glassman steven mark Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-09-13 | Stein John Nachum Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-08-23 | Stein John Nachum Director | Purchase | +10,000 | $2.50 | $25K | 471,820 |
| 2024-08-23 | Stein John Nachum Director | Grant or award · Warrant to Purchase Common Stock | +5,000 | 5,000 | ||
| 2024-08-23 | glassman steven mark Director | Purchase | +10,000 | $2.50 | $25K | 145,025 |
| 2024-08-23 | glassman steven mark Director | Grant or award · Warrant to Purchase Common Stock | +5,000 | 5,000 | ||
| 2024-08-23 | ZELDIS JEROME B Director | Purchase | +10,000 | $2.50 | $25K | 103,028 |
| 2024-08-23 | ZELDIS JEROME B Director | Grant or award · Warrant to Purchase Common Stock | +5,000 | 5,000 | ||
| 2024-08-23 | Henry Scott Robert Director | Purchase | +10,000 | $2.50 | $25K | 145,735 |
Page 5 of 9 · 176 trades